4//SEC Filing
Hamel Lawrence G 4
Accession 0001437749-17-016405
CIK 0001427925other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 4:54 PM ET
Size
4.8 KB
Accession
0001437749-17-016405
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Sale
Common Stock
2017-09-25−13,827→ 68,504 total(indirect: See footnote)
Footnotes (3)
- [F1]52,125 of the Shares are held in the Hamel Revocable Living Trust
- [F2]The Shares were sold in a range from $3.50-$4.50
- [F3]Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511368
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 4:54 PM ET
- Size
- 4.8 KB